#88: Jia En Chin, Shirley Lu, Thijs Spoor: New Opportunities for Biotechs in China
Podcast |
Beginner's Mind
Publisher |
Christian Soschner
Media Type |
audio
Categories Via RSS |
Business
Entrepreneurship
Investing
Technology
Publication Date |
Oct 04, 2022
Episode Duration |
01:20:07

What are the opportunities for Biotechs in the Chinese Market? Get answers to this question in this podcast with the BFC Group.⭐We are talking aboutThe BFC GroupThe Capital Market Landscape in ChinaDeal Structuring in ChinaClinical Strategies for ChinaWhy Affordability and Accessibility of new drugs matter in China⭐About BFC Group:BFC Group is a China-based investment banking firm with a focus on healthcare M&A, licensing, and financing.  We work with leading healthcare companies in the US, Europe, and Asia.  With first-hand operational experience in both the US and China, we have a deep understanding of the challenges our clients face when establishing or expanding their companies’ presence outside of their home market.  ⭐ EPISODE Links:Jia En ChinThijs SpoorShirley Lu:BFC Group: Youtube Presentation best viewed on Youtube🎤 Quotes:(26:04) “China is now the second largest pharma market in the world, Japan being third” (31:11) “Many of our clients are still in Clinical Phase I, when they come to China”(33:29) “The China Market really rewards innovation in antibiotic research.”(48:30) “China takes care to make therapeutics accessible and affordable for the population”(51:24) “China's growing middle class wants to improve their quality of life.”(59:45) “Finding the right partner for a Go-To-China-Strategy is key to success. Otherwise, it can become very costly and might damage the asset.”(01:00:38) "... you want a personal connection, you want to educate and not sell..."(01:16:30) “In Q1/2022 18 new drugs were approved in China, 12 of them came from The West.”🕛 Timestamps:(00:00) Introductions(13:00) BFC Group Introduction to the Chinese Market(15:45) Capital Market Landscape in China(18:30) China Investment and Financing Trend(21:43) Licensing Deal Trends in China(25:00) Opportunities for Biotechs in China(25:45) The biggest Pharma Markets and Innovators  (30:00) Deal-Focus of Chinese Pharma Companies(32:00) The Therapeutic Focus in China in 2022(33:41) Antibiotics Research in China(36:40) The Major Player in Infectious Diseases and Cancer on the Chinese Market (38:00) Market Potential in

How to Start a Podcast Guide: The Complete GuideLearn how to plan, record, and launch your podcast with this illustrated guide. Make More with Matt HeslinExplore strategies to thrive financially, build legacy, and enhance life experiences.

Listen on: Apple Podcasts   Spotify

Coaching Conversations in 2024

In 2024 we're going to be going to monthly themes and I would also encourage you to...

Listen on: Apple Podcasts   Spotify

The LSG2G PartnersExperts in Life ScienceDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.

Support the Show.

Join the Podcast Newsletter: Link

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review